Alexandre Perrier

439 total citations
17 papers, 215 citations indexed

About

Alexandre Perrier is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Alexandre Perrier has authored 17 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Alexandre Perrier's work include Genetic factors in colorectal cancer (2 papers), Peptidase Inhibition and Analysis (2 papers) and HER2/EGFR in Cancer Research (2 papers). Alexandre Perrier is often cited by papers focused on Genetic factors in colorectal cancer (2 papers), Peptidase Inhibition and Analysis (2 papers) and HER2/EGFR in Cancer Research (2 papers). Alexandre Perrier collaborates with scholars based in France and Switzerland. Alexandre Perrier's co-authors include Mathieu Boissan, Guillaume Lefèvre, Joseph Gligorov, Simon Garinet, Audrey Didelot, Pierre Laurent‐Puig, Hélène Blons, Éva Compérat, Jean‐Pierre Lotz and Guillaume Beinse and has published in prestigious journals such as PLoS ONE, Oncogene and British Journal of Cancer.

In The Last Decade

Alexandre Perrier

15 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Perrier France 6 106 81 58 38 31 17 215
Liantao Guo China 7 92 0.9× 121 1.5× 76 1.3× 55 1.4× 42 1.4× 14 266
Qian Guo China 8 80 0.8× 83 1.0× 42 0.7× 37 1.0× 30 1.0× 33 180
Fatma Althoubaity Saudi Arabia 6 109 1.0× 86 1.1× 93 1.6× 42 1.1× 22 0.7× 10 253
Vignesh Viswanathan United States 11 159 1.5× 94 1.2× 113 1.9× 52 1.4× 29 0.9× 32 344
Dengjie Ouyang China 8 103 1.0× 67 0.8× 73 1.3× 40 1.1× 24 0.8× 24 225
Franziska Niehr Germany 8 175 1.7× 136 1.7× 77 1.3× 56 1.5× 18 0.6× 10 276
Yuanhao Liu China 8 79 0.7× 52 0.6× 52 0.9× 43 1.1× 13 0.4× 20 186
Huiyu Lu China 11 120 1.1× 144 1.8× 76 1.3× 82 2.2× 35 1.1× 29 303
Yuko Nakazawa Japan 11 62 0.6× 125 1.5× 51 0.9× 42 1.1× 55 1.8× 39 380
Ji‐Hye Oh South Korea 9 91 0.9× 92 1.1× 72 1.2× 59 1.6× 14 0.5× 14 220

Countries citing papers authored by Alexandre Perrier

Since Specialization
Citations

This map shows the geographic impact of Alexandre Perrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Perrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Perrier more than expected).

Fields of papers citing papers by Alexandre Perrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Perrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Perrier. The network helps show where Alexandre Perrier may publish in the future.

Co-authorship network of co-authors of Alexandre Perrier

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Perrier. A scholar is included among the top collaborators of Alexandre Perrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Perrier. Alexandre Perrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bisdorff, Annouk, Alexandre Perrier, Erell Guillerm, et al.. (2025). Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital. Molecular Diagnosis & Therapy. 29(3). 367–380.
3.
Didelot, Audrey, Simon Garinet, Aurélien de Reyniès, et al.. (2024). PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up. Oncogene. 43(37). 2781–2794. 3 indexed citations
4.
Perrier, Alexandre, et al.. (2023). Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports. Frontiers in Oncology. 13. 1182558–1182558. 3 indexed citations
5.
Perrier, Alexandre, et al.. (2022). Cholangiocarcinomes avancés et gènes de fusion. Bulletin du Cancer. 109(11). 11S28–11S34. 1 indexed citations
6.
Tauziède‐Espariat, Arnault, Léa Guerrini‐Rousseau, Alexandre Perrier, et al.. (2022). Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma. Acta Neuropathologica. 143(4). 523–525. 2 indexed citations
7.
Perrier, Alexandre, Pierre Hainaut, Pierre‐Jean Lamy, et al.. (2022). Utilisation clinique et évolution des biomarqueurs circulants à l’ère de l’oncologie personnalisée : des marqueurs protéiques aux scores clinicobiologiques. Bulletin du Cancer. 109(2). 151–169. 5 indexed citations
8.
Eyries, Mélanie, Erell Guillerm, Alexandre Perrier, et al.. (2022). Detection of a pathogenic Alu element insertion in PALB2 gene from targeted NGS diagnostic data. European Journal of Human Genetics. 30(10). 1187–1190. 1 indexed citations
9.
Perrier, Alexandre, Pierre Hainaut, Pierre‐Jean Lamy, et al.. (2022). En marche vers une oncologie personnalisée : l’apport des techniques génomiques et de l’intelligence artificielle dans l’usage des biomarqueurs tumoraux circulants. Bulletin du Cancer. 109(2). 170–184. 5 indexed citations
10.
Passeri, Thibault, Lorenzo Giammattei, Rosaria Abbritti, et al.. (2021). Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization. Acta Neurochirurgica. 164(1). 255–263. 10 indexed citations
11.
Garinet, Simon, Audrey Didelot, Thomas Denize, et al.. (2021). Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC. British Journal of Cancer. 125(11). 1544–1551. 20 indexed citations
12.
Perrier, Alexandre, Pierre‐Yves Boëlle, Yves Chrétien, et al.. (2020). An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies. PLoS ONE. 15(1). e0227356–e0227356. 18 indexed citations
13.
Perrier, Alexandre, Audrey Didelot, Pierre Laurent‐Puig, Hélène Blons, & Simon Garinet. (2020). Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors. Biomolecules. 10(7). 1061–1061. 72 indexed citations
14.
Denis, Jérôme Alexandre, Alexandre Perrier, Juliette Nectoux, et al.. (2019). Development of molecular analyzes by digital PCR for clinical practice: positioning, current applications and perspectives. Annales de biologie clinique. 77(6). 619–637. 3 indexed citations
15.
Perrier, Alexandre, Joseph Gligorov, Guillaume Lefèvre, & Mathieu Boissan. (2018). The extracellular domain of Her2 in serum as a biomarker of breast cancer. Laboratory Investigation. 98(6). 696–707. 70 indexed citations
16.
Perrier, Alexandre, et al.. (2014). [Atrial fibrillation and obstructive sleep apnea: a fortuitous association?].. PubMed. 10(446). 1913–7. 1 indexed citations
17.
Perrier, Alexandre, et al.. (2006). [Nesiritide in heart failure: commercial success or therapeutic advance?].. PubMed. 2(50). 295–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026